Logo for Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Investor Relations Material

Latest events

Logo for Arcutis Biotherapeutics Inc

Q1 2024

Arcutis Biotherapeutics
Logo for Arcutis Biotherapeutics

Q1 2024

14 May, 2024
Logo for Arcutis Biotherapeutics

Q4 2023

27 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Arcutis Biotherapeutics Inc

Access all reports
Arcutis BioTherapeutics, Inc., is focused on developing and commercializing treatments for dermatological diseases. The Company's lead product is setroxidil lotion, an investigational drug candidate designed to be applied topically to the scalp that can help to stimulate hair follicles into producing new hair. The Company also develops depigmenting agents for pigmentary disorders of the skin and lips.